Orchid Chemicals’ cephalosporin producing facility at Alathur in Chennai has reopened and the production will commence immediately
Drug firm Orchid Chemicals & Pharmaceuticals said it had resumed production at its unit in Chennai. "The company's cephalosporin producing facility at Alathur in Chennai has reopened and the production will commence immediately," Orchid Chemicals & Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE).
The company's cephalosporin producing facility at Alathur in Chennai was issued a closure notice by the Tamil Nadu Pollution Control Board (TNPCB) citing some non-compliance with regard to the disposal of solid waste in July this year. The Alathur facility manufactures a range of oral and sterile cephalosporin APIs and caters to developed markets like the US, Europe and Japan. Cephalosporins are a newer class of antibiotics used in treating infections in different parts of the body.
On Wednesday, Orchid Chemicals ended 0.07% down at Rs202.55 on the Bombay Stock Exchange, while the benchmark Sensex gained 0.66% to 16,840.80.
During the entire 2010-11 fiscal, the company had sold 22.43 million sq ft for Rs2,392.7 crore
Realty firm Ansal Properties and Infrastructure said it has sold 9.54 million sq ft of area for Rs1,138 crore during the first four months of the current fiscal.
During the entire 2010-11 fiscal, the company had sold 22.43 million sq ft for Rs2,392.7 crore. "Total area sold in four months ended FY2012 increased to
9.54 million sq ft, aggregating to total sale value of Rs1,138.1 crore," Ansal said in latest operational updates.
The average realisation stood at Rs1,433 per sq ft in July 2011 against Rs1,404 a sq ft in the previous month. "Major sales booked in Phase I and Phase II of Sushant Golf City, Lucknow during the month (July)," the company said.
Ansal had recently reported a nearly 44% decline in consolidated net profit at Rs21.74 crore for the quarter ended 30 June due to higher expenditure on construction. The company had posted a net profit of Rs38.79 crore in the year-ago period.
The total income, however, increased by 16.42% to Rs297.01 crore in the first quarter of this fiscal against Rs255.12 crore in the corresponding period of last fiscal. Ansal's total expenditure grew to Rs245.17 crore during the June quarter of 2011-12 fiscal from Rs182.98 crore in the year-ago period.
On Wednesday, Ansal Properties ended 6.49% down at Rs28.10 on the Bombay Stock Exchange, while the benchmark Sensex gained 0.66% to 16,840.80.
The fall in the wholesale numbers is due to lower demand for Tata passenger cars
Tata Motors group global sales, including Jaguar Land Rover (JLR), fell 6% to 85,392 units in July. The fall in the wholesale numbers is due to lower demand for Tata passenger cars, as well as Fiat and Jaguar.
The global sales of Tata passenger vehicles and the distribution off-take in India of Fiat cars were down by 38% in July at 19,035 units for the month on a year-on-year basis. Jaguar sales for the month fell 23% to 4,372 units on a year-on-year basis.
Overall passenger vehicle (PV) sales of Tata Motors in India too declined in June quarter by 11%. This includes Fiat and JLR vehicles distributed in India.
The company's global commercial vehicle range including Tata, Tata Daewoo and the Tata Hispano Carrocera vehicles grew by 16% to 47,238 units in July on a year-on-year basis. Even Land Rover brand standalone continued its growth in July with wholesales at 14,747 units, higher by 8%.
During the period extending between April to July, Tata Motors global wholesales grew by 4% to 350,565 compared to the corresponding period in 2010-11.
On Wednesday, Tata Motors ended 2.8% down at Rs779.30 on the Bombay Stock Exchange, while the benchmark Sensex gained 0.66% to 16,840.80.